7 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Symbia SPECT and SPECT/CT Systems

FDA 510(k)
FDA Class 2 ·Radiology

Clear Guide SCENERGY

FDA 510(k)
FDA Class 2 ·Radiology

CLINIQA LIQUID QC TDM CONTROLS LEVELS 1,2 & 3/CLINIQA LINICAL TDM CALIBRATION VERIFIERS LEVELS A-E FOR OLYMPUS AU SYSTEM

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM 9.75 CM NON US

FDA Adverse Event
Malfunction ·COSTA RICA·Product code LTI·November 18, 2008

DIGOXIN

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code KXT·September 9, 2011

GYNECARE PROLIFT ANTERIOR PELVIC FLOOR REPAIR SYSTEM

FDA Adverse Event
Injury ·ETHICON INC.·Product code OTP·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014